Effect of bovine lactoferrin on functions of activated feline peripheral blood mononuclear cells during chronic feline immunodeficiency virus infection

Journal of Veterinary Medical Science

Volumn 70, Issue 5, 2008, Pages 429-435

  Kobayashi, Saori ^a   Sato, Reeko ^a   Aoki, Takako ^a   Omoe, Katsuhiko ^a   Inanami, Osamu ^b   Hankanga, Careen ^a   Yamada, Yuichi ^a,c   Tomizawa, Nobuyuki ^a   Yasuda, Jun ^a   Sasaki, Juso ^a  

^a IWATE UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

Anti inflammatory activity; Bovine lactoferrin; FIV infected cat; Persistent immune activation

Indexed keywords

CONCANAVALIN A; CYTOKINE; LACTOFERRIN; MESSENGER RNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CATTLE; CELL PROLIFERATION; CHRONIC DISEASE; CYTOLOGY; DRUG EFFECT; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MONONUCLEAR CELL; RETROVIRUS INFECTION; VIROLOGY;

ANIMALS; CAT DISEASES; CATS; CATTLE; CELL PROLIFERATION; CHRONIC DISEASE; CONCANAVALIN A; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; IMMUNODEFICIENCY VIRUS, FELINE; LACTOFERRIN; LENTIVIRUS INFECTIONS; LEUKOCYTES, MONONUCLEAR; MALE; RNA, MESSENGER;

BOVINAE; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS;

EID: 44849098471     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.70.429     Document Type: Article

References (38)

1. Artym, J., Zimecki, M., Paprocka, M. and Kruzel, M.L. 2003. Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol. Lett. 89: 9-15.
2. Crouch, S.P., Slater, K.J. and Fletcher, J. 1992. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80: 235-240.
3. Damiens, E., El Yazidi, I., Mazurier, J., Duthille, I., Spik, G. and Boilly-Marer, Y. 1999. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J. Cell. Biochem. 74: 486-498.
4. de Parseval, A., Chatterji, U., Sun, P. and Elder, J.H. 2004. Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. U.S.A. 101: 13044-13049.
5. Dhennin-Duthille, I., Masson, M., Damiens, E., Fillebeen, C., Spik, G. and Mazurier, J. 2000. Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J. Cell Biochem. 79: 583-593.
6. Giorgi, J.V., Hultin, L.E., McKeating, J.A., Johnson, T.D., Owens, B., Jacobson, R.L.P., Shih, R., Lewis, J., Wiley, D.J., Phair, J.P., Wolinsky, S.M. and Detels, R. 1999. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179: 859-870.
7. Hankanga, C., Kobayashi, S., Yamada, Y., Momota, Y., Sato, R. and Yasuda, J. 2007. Adenosine deaminase activity in cats infected with feline immunodeficiency virus. J. Vet. Med. Sci. 69: 881-885.
8. Hazenberg, M.D., Otto, S.A., van Benthem, B.H., Roos, M.T., Coutinho, R.A., Lange, J.M., Hamann, D., Prins, M. and Miedema, F. 2003.Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 17: 1881-1888.
9. He, J. and Furmanski, P. 1995. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373: 721-724.
10. Heideman, M. and Bengtsson, A. 1985. Immunological interference of high dose corticosteroids. Acta. Chir. Scand. Suppl. 526: 48-55.
11. Hober, D., Benyoucef, S., Chieux, V., De Groote, D., De La Tribonniere, X., Bocket, L., Lion, G., Mouton, Y. and Wattré, P. 1999. Specific immune response to human immunodeficiency virus (HIV)-1 in patients assessed through the production of interferon-gamma and interleukin-4 in HIV-1 p24-activated whole blood cultures: relationship with the viral load in plasma. Scand. J. Immunol. 50: 83-90.
12. Hohdatsu, T., Nakanishi, T., Saito, I. and Koyama, H. 2005. Ability of CD8+ T cell anti-feline immunodeficiency virus (FIV) activity and FIV proviral DNA load in mononuclear cells in FIV-infected cats. J. Vet. Med. Sci. 67: 129-131.
13. Ishida, T. and Tomoda, I. 1990. Clinical staging of feline immunodeficiency virus infection. Jpn. J. Vet. Sci. 52: 645-648.
14. Joshi, A., Vahlenkamp, T.W., Garg, H., Tompkins, W.A. and Tompkins, M.B. 2004. Preferential replication of FIV in activated CD4(+)CD25(+)T cells independent of cellular proliferation. Virology 321: 307-322.
15. Kobayashi, S., Sato, R., Inanami, O., Yamamori, T., Yamato, O., Maede, Y., Sato, J., Kuwabara, M. and Naito, Y. 2005. Reduction of concanavalin A-induced expression of interferon-gamma by bovine lactoferrin in feline peripheral blood mononuclear cells. Vet. Immunol. Immunopathol. 105: 75-84.
16. Lawrence, C.E., Callanan, J.J., Willett, B.J. and Jarrett, O. 1995. Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study. Immunology 85: 568-574.
17. Legrand, D., Elass, E., Carpentier, M. and Mazurier, J. 2005. Lactoferrin: a modulator of immune and inflammatory responses. Cell. Mol. Life. Sci. 62: 2549-2559.
18. Mader, J.S., Salsman, J., Conrad, D.M. and Hoskin, D.W. 2005. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol. Cancer Ther. 4: 612-624.
19. Mincheva-Nilsson, L., Hammarstrom, M.L., Juto, P. and Hammarstrom, S. 1990. Human milk contains proteins that stimulate and suppress T lymphocyte proliferation. Clin. Exp. Immunol. 79: 463-469.
20. Mincheva-Nilsson, L., Hammarstrom, S. and Hammarstrom, M.L. 1997. Activated human gamma delta T lymphocytes express functional lactoferrin receptors. Scand. J. Immunol. 46: 609-618.
21. Moed, H., Stoof, T.J., Boorsma, D.M., von Blomberg, B.M., Gibbs, S., Bruynzeel, D.P., Scheper, R.J. and Rustemeyer, T. 2004. Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles. Clin. Exp. Allergy 34: 1868-1875.
22. Ostrowski, M.A., Krakauer, D.C., Li, Y., Justement, S.J., Learn, G., Ehler, L.A., Stanley, S.K., Nowak, M. and Fauci, A.S. 1998. Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J. Virol. 72: 7772-7784.
23. Paillot, R., Richard, S., Bloas, F., Piras, F., Poulet, H., Brunet, S., Andreoni, C. and Juillard, V. 2005. Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders. Vet. Immunol. Immunopathol. 106: 1-14.
24. Pedersen, N.C., Ho, E.W., Brown, M.L. and Yamamoto, J.K. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235: 790-793.
25. Richie, E.R., Hilliard, J.K., Gilmore, R. and Gillespie, D.J. 1987. Human milk-derived lactoferrin inhibits mitogen and alloantigen induced human lymphocyte proliferation. J. Reprod. Immunol. 12: 137-148.
26. Rideout, B.A., Moore, P.F. and Pedersen, N.C. 1992. Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus. Vet. Immunol. Immunopathol. 35: 71-81.
27. Sato, R., Inanami, O., Tanaka, Y., Takase, M. and Naito, Y. 1996. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV)-positive and FIV-negative cats. Am. J. Vet. Res. 57: 1443-1446.
28. Shau, H., Kim, A. and Golub, S.H. 1992. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukoc. Biol. 51: 343-349.
29. Shimazaki, K., Tanaka, T., Kon, H., Oota, K., Kawaguchi, A., Maki, Y. and Sato, T. 1993. Separation and characterization of the C-terminal half molecule of bovine lactoferrin. J. Dairy Sci. 76: 946-955.
30. Siebelink, K.H., Chu, I.H., Rimmelzwaan, G.F., Weijer, K., van Herwijnen, R., Knell, P., Egberink, H.F., Bosch, M.L. and Osterhaus, A.D. 1990. Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS. Res. Hum. Retroviruses 6: 1373-1378.
31. Silvotti, L., Kramer, L., Corradi, A., Busani, L., Tedeschi, F., Brandi, G., Bendinelli, M. and Piedimonte, G. 1997. Modulation of host cell activation during feline immunodeficiency virus (FIV) infection. J. Comp. Pathol. 116: 263-271.
32. Sirriyah, J., Dean, G.A., LaVoy, A. and Burkhard, M.J. 2004. Assessment of CD4+ and CD8+ IFN-gamma producing cells by ELISPOT in naive and FIV-infected cats. Vet. Immunol. Immunopathol. 102: 77-84.
33. Togawa, J., Nagase, H., Tanaka, K., Inamori, M., Umezawa, T., Nakajima, A., Naito, M., Sato, S., Saito, T. and Sekihara, H. 2002. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G187-195
34. Wolf, J.S., Li, G., Varadhachary, A., Petrak, K., Schneyer, M., Li, D., Ongkasuwan, J., Zhang, X., Taylor, R.J., Strome, S.E. and O'Malley, B.W. 2007. Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clin. Cancer Res. 13: 1601-1610.
35. Wong, C.W., Seow, H.F., Husband, A.J., Regester, G.O. and Watson, D.L.1997. Effects of purified bovine whey factors on cellular immune functions in ruminants. Vet. Immunol. Immunopathol. 56: 85-96.
36. Zimecki, M., Miedzybrodzki, R. and Szymaniec, S. 1998.Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production. Arch. Immunol. Ther. Exp. (Warsz) 46: 361-365.
37. Zimecki, M., Stepniak, D., Szynol, A. and Kruzel, M.L. 2001. Lactoferrin regulates proliferative response of human peripheral blood mononuclear cells to phytohemagglutinin and mixed lymphocyte reaction. Arch. Immunol. Ther. Exp. (Warsz) 49: 147-154.
38. Zuccotti, G.V., Salvini, F., Riva, E. and Agostoni, C. 2006. Oral lactoferrin in HIV-1 vertically infected children: an observational follow-up of plasma viral load and immune parameters. J. Int. Med. Res. 34: 88-94.